NCT05021562View on ClinicalTrials.gov

A Study of Niraparib in Patients With Ovarian Cancer in Clinical Practice

Active, not recruitingOBSERVATIONAL

Enrollment

354

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions

Ovarian Cancer

Interventions

DRUG

Niraparib

Niraparib capsules

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY